Innovating Works

H2020

Cerrada
HORIZON-MISS-2023-CANCER-...
HORIZON-MISS-2023-CANCER-01-04: Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions
ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 12-04-2023.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes

Childhood cancer patients, survivors and their families benefit from enhanced quality of life through better supportive care, personalised counselling approaches, and digital tools that are accessible and affordable. Consequently, they can better achieve their values and personal life goals.Health care professionals, supportive workers and councillors enhance the quality of life for childhood cancer patients, survivors and their families.
Scope:Best practices and tools to improve the quality of life for survivors of childhood cancer exist at national, regional and local level. These practices and tools should be scaled up or deployed in regions in at least three different Member States or Associated Countries in order to serve as demonstrators for wider uptake.

Proposals should address all of the following:

Best practices and validated tools (such as digital tools) related to for example education, sports, employment, medical follow-up including mental and physical healt... ver más

ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes

Childhood cancer patients, survivors and their families benefit from enhanced quality of life through better supportive care, personalised counselling approaches, and digital tools that are accessible and affordable. Consequently, they can better achieve their values and personal life goals.Health care professionals, supportive workers and councillors enhance the quality of life for childhood cancer patients, survivors and their families.
Scope:Best practices and tools to improve the quality of life for survivors of childhood cancer exist at national, regional and local level. These practices and tools should be scaled up or deployed in regions in at least three different Member States or Associated Countries in order to serve as demonstrators for wider uptake.

Proposals should address all of the following:

Best practices and validated tools (such as digital tools) related to for example education, sports, employment, medical follow-up including mental and physical health and well-being, or reproductive matters, should be tested and scaled up in regions in at least three different Member States or Associated Countries;Address hurdles, factors and situations that impede implementation of good practices and tools in real-life settings with the intention to make the life of childhood cancer survivors easier and better. Effectiveness and general applicability should be assessed and evaluated to provide enhanced real solutions in practice;Attention should be paid to social and health determinants, including sex, gender, age and other relevant variables, such as socio-economic status, living in rural or remote areas and education;Several best practices and tools should be chosen and scaled up together with childhood cancer survivors and their families. The use of participative research models, such as oncology-centred living labs[1] or other approaches to deliver (social) innovation should be considered. This topic requires the effective contribution of SSH disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.

The successful proposal is expected to liaise with and build on resources made available by the Knowledge Centre on Cancer (KCC)[2] in order to foster EU alignment and coordination.

Successful applicants should closely monitor and take into account the outcomes of the project supported under topic HORIZON-MISS-2021-CANCER-02-02, (Develop and validate a set of quality of life and patient preference measures for cancer patients and survivors[3]).

The Commission will facilitate Mission-specific coordination through future actions. Hence, successful applicants will be asked to join the ‘Quality of life’ cluster for the Mission on Cancer together with the aforementioned project[4]. In this regard, the Commission will take on the role of facilitator, including with relevant initiatives and stakeholders, if appropriate.

Therefore, proposals should include a budget for networking, attendance at meetings, and potential joint activities without the prerequisite to give details of these at this stage. Examples of these activities are the organisation of joint workshops, the exchange of knowledge, the establishment best practices, or the initiation of joint communication activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate.

The details of joint activities will be defined during the grant agreement preparation phase and during the life of the project.


[1]https://enoll.org/

[2]Hosted by the European Commission's Joint Research Centre (JRC). Especially through the ’European Guidelines and Quality Assurance Schemes for Breast, Colorectal and Cervical Cancer Screening and Diagnosis‘, and the ’European Cancer Information System (ECIS)’ and the ’European Cancer Inequalities Registry (ECIR), see https://knowledge4policy.ec.europa.eu/cancer_en

[3]https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-miss-2021-cancer-02-02

[4]In order to address the objectives of the Mission on Cancer, participants will collaborate in project clusters to leverage EU-funding, increase networking across sectors and disciplines, and establish a portfolio of Cancer Mission R&I and policy actions.

ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: *Presupuesto para cada participante en el proyecto
Requisitos técnicos: ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Subcontracting costs.
Purchase costs.
Other cost categories.
Indirect costs.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 6:. Representa un paso importante en demostrar la madurez de una tecnología. Se construye un prototipo de alta fidelidad que aborda adecuadamente las cuestiones críticas de escala, que opera en un entorno relevante, y que debe ser a su vez una buena representación del entorno operativo real. + info.
TRL esperado:
Estadísticas proyectos financiados: Te facilitamos algunas estadísticas de los últimos 5 proyectos tramitados conocidos por categoría de empresa, porcentaje y presupuesto medio.

Categoria

%

Presupuesto medio

Grande

100%

0€

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
Para el presupuesto subvencionable la intensidad de la ayuda en formato fondo perdido podrá alcanzar desde un 70% hasta un 100%.
The funding rate for IA projects is 70 % for profit-making legal entities and 100 % for non-profit legal entities. The funding rate for IA projects is 70 % for profit-making legal entities and 100 % for non-profit legal entities.
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea pero en los últimos 6 meses la línea ha concecido
Total concedido en los últimos 6 meses.
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
HORIZON-MISS-2023-CANCER-01 Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the...
Sin info.
HORIZON-MISS-2023-CANCER-01-03 Pragmatic clinical trials on minimally invasive diagnostics
en consorcio: ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the...
Cerrada hace 1 año | Próxima convocatoria prevista para el mes de
HORIZON-MISS-2023-CANCER-01-01 Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients.
en consorcio: ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards, and to contribute to all of...
Cerrada hace 1 año | Próxima convocatoria prevista para el mes de
HORIZON-MISS-2023-CANCER-01-04 Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions
en consorcio: ExpectedOutcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the...
Cerrada hace 1 año | Próxima convocatoria prevista para el mes de
HORIZON-MISS-2023-CANCER-01-02 Enhance primary cancer prevention through sustainable behavioural change
en consorcio: ExpectedOutcome:Enhance interventions and scale these up in different geographical, socio-economic and cultural settings as well as in diffe...
Cerrada hace 1 año | Próxima convocatoria prevista para el mes de